Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence SHALQLNNR
Primary information
sequence IDSeq_7180
Peptide sequenceSHALQLNNR
CancerPDF_ID CancerPDF_ID1898, CancerPDF_ID3158, CancerPDF_ID9453,
PMID21136997,21136997,26379225
Protein NameComplement C4-B,Complement C4-A,Complement C4-A/Complement C4-B
UniprotKB Entry NameCO4B_HUMAN,CO4A_HUMAN,"CO4A_HUMAN,CO4B_HUMAN"
FluidSerum,Plasma,Plasma
M/Z1051.55229,1051.5523,1052.56
Charge1,1,NA
Mass (in Da)NA,NA,NA
fdrNA,NA,NA
Profiling TechniqueLC-MS,LC-MS,MALDI-TOF
Peptide Identification techniqueLC-MS-MS/MS,LC-MS-MS/MS,MALDI-TOF/TOF
Quantification TechniqueLC-ESI-MS,LC-ESI-MS,NA
Labelled/Label FreeLabel Free,Label Free,Label Free
FDRNA,NA,NA
CancerPDF_ID CancerPDF_ID1898, CancerPDF_ID3158, CancerPDF_ID9453,
p-ValueNA,NA,NA
SoftwareMASCOT(v. 2.2.01),MASCOT(v. 2.2.01),MASCOT (v 2.3)
Length9,9,9
Cancer TypeColorectal cancer,Normal,Colorectal cancer
DatabaseSwissProt Database,SwissProt Database,UniprotKB
ModificationNA,NA,NA
Number of Patients30 patients and 30 healthy controls,27 healthy individuals,"94 patients with CRC, 23 with liver metastasis from CRC (histologically defined) and 34 subjects, which underwent colonoscopy and resulted negative"
RegulationNA,NA,"Intensity was similar to controls, controversially, in adenoma and CRC groups was highest. "
ValidationLeave One out Cross validation,Leave One out Cross validation,NA
SensitivityNA,NA,NA
SpecificityNA,NA,NA
AccuracyNA,NA,NA
Peptide AtlasPeptideAtlas
IEDB